These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29229837)

  • 21. Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease.
    Drouvalakis KA; Buchanan RR
    J Rheumatol; 1998 Feb; 25(2):290-5. PubMed ID: 9489821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid syndrome: critical analysis of the diagnostic path.
    Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
    Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of phospholipid-specific assays for the evaluation of antiphospholipid syndrome.
    Tebo AE; Jaskowski TD; Phansalkar AR; Litwin CM; Branch DW; Hill HR
    Am J Clin Pathol; 2008 Jun; 129(6):870-5. PubMed ID: 18480002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of Phosphatidylethanolamine Concentration and Composition on the Detection of Antiphosphatidylethanolamine Antibodies by ELISA.
    Ke K; Strango ZI; Harper PE; Zhao M
    J Clin Lab Anal; 2016 Sep; 30(5):689-96. PubMed ID: 27061173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome.
    Du VX; Kelchtermans H; de Groot PG; de Laat B
    Thromb Res; 2013 Sep; 132(3):319-26. PubMed ID: 23958468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of anti-phosphatidylethanolamine antibodies using flow cytometry.
    Drouvalakis KA; Neeson PJ; Buchanan RR
    Cytometry; 1999 May; 36(1):46-51. PubMed ID: 10331626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiphospholipid syndrome, "the best prophet of the future".
    Amengual O; Atsumi T
    Mod Rheumatol; 2018 May; 28(3):409-416. PubMed ID: 29385876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome.
    Yalavarthi S; Gould TJ; Rao AN; Mazza LF; Morris AE; Núñez-Álvarez C; Hernández-Ramírez D; Bockenstedt PL; Liaw PC; Cabral AR; Knight JS
    Arthritis Rheumatol; 2015 Nov; 67(11):2990-3003. PubMed ID: 26097119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus.
    Karmochkine M; Berard M; Piette JC; Cacoub P; Aillaud MF; Harlé JR; Godeau P; Boffa MC; Harlet JR
    Lupus; 1993 Jun; 2(3):157-60. PubMed ID: 8369806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein.
    Tzang BS; Lee YJ; Yang TP; Tsay GJ; Shi JY; Tsai CC; Hsu TC
    Clin Chim Acta; 2007 Jul; 382(1-2):31-6. PubMed ID: 17451664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.
    Rand JH; Wu XX; Andree HA; Lockwood CJ; Guller S; Scher J; Harpel PC
    N Engl J Med; 1997 Jul; 337(3):154-60. PubMed ID: 9219701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease?
    Chen Q; Stone PR; Woon ST; Ching LM; Hung S; McCowan LM; Chamley LW
    Thromb Res; 2004; 114(2):101-11. PubMed ID: 15306152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial and platelet microparticles in patients with antiphospholipid antibodies.
    Breen KA; Sanchez K; Kirkman N; Seed PT; Parmar K; Moore GW; Hunt BJ
    Thromb Res; 2015 Feb; 135(2):368-74. PubMed ID: 25496997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of anti-phospholipid antibody specificities.
    Gilman-Sachs A; Lubinski J; Beer AE; Brend S; Beaman KD
    J Clin Lab Immunol; 1991 Jun; 35(2):83-8. PubMed ID: 1668762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical value of testing for antibodies to phosphatidylethanolamine (aPE) in patients with systemic lupus erythematosus (SLE).
    Bertolaccini ML; Murru V; Sciascia S; Sanna G; Khamashta MA
    Thromb Res; 2012 Dec; 130(6):914-8. PubMed ID: 23079292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome.
    Kajiwara T; Yasuda T; Matsuura E
    J Autoimmun; 2007; 29(2-3):164-73. PubMed ID: 17826950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss.
    Sugi T; Matsubayashi H; Inomo A; Dan L; Makino T
    J Obstet Gynaecol Res; 2004 Aug; 30(4):326-32. PubMed ID: 15238112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-endothelial antibodies and defects of heart valves in antiphospholipid syndrome: analysis of pathogenic mechanisms].
    Nasonov EL; Salozhin KV; Fomicheva OA; Kliukvina NG; Karpov IA; Vil'chinskaia MI; Aleksandrova EN; Alekberova ZS; Baranov AA; Sergakova LM; Kotel'nikova GP; Le Tonqueze M; Nasonova VA; Youinou P
    Klin Med (Mosk); 1997; 75(2):17-22. PubMed ID: 9157207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.